Easywell Biomedicals Balance Sheet Health
Financial Health criteria checks 6/6
Easywell Biomedicals has a total shareholder equity of NT$623.8M and total debt of NT$43.3M, which brings its debt-to-equity ratio to 6.9%. Its total assets and total liabilities are NT$1.2B and NT$590.0M respectively.
Key information
6.9%
Debt to equity ratio
NT$43.27m
Debt
| Interest coverage ratio | n/a |
| Cash | NT$348.03m |
| Equity | NT$623.80m |
| Total liabilities | NT$589.99m |
| Total assets | NT$1.21b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 1799's short term assets (NT$507.6M) exceed its short term liabilities (NT$127.6M).
Long Term Liabilities: 1799's short term assets (NT$507.6M) exceed its long term liabilities (NT$462.4M).
Debt to Equity History and Analysis
Debt Level: 1799 has more cash than its total debt.
Reducing Debt: 1799's debt to equity ratio has reduced from 12.6% to 6.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1799 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1799 has sufficient cash runway for 1.9 years if free cash flow continues to grow at historical rates of 21.3% each year.